Breckenridge announces launch of Tofacitinib Tablets, generic equivalent of Xeljanz® by Pfizer
BERKELEY HEIGHTS, N.J., June 4, 2026 /PRNewswire/ -- Breckenridge Pharmaceutical, Inc., the U.S. subsidiary of Towa International that markets, distributes, and sells generic medicines in the United States, announced the launch of Tofacitinib Tablets, the generic equivalent of Xeljanz® by...
BERKELEY HEIGHTS, N.J., June 4, 2026 /PRNewswire/ -- Breckenridge Pharmaceutical, Inc., the U.S. subsidiary of Towa International that markets, distributes, and sells generic medicines in the United States, announced the launch of Tofacitinib Tablets, the generic equivalent of Xeljanz® by...
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.